๐ฐ Section Chief News
Page 6 - Section Chief News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Section Chief. Real-time updates on events, politics, business and more.
December 9, 2023
Vertex and CRISPR Therapeutics have announced FDA approval for CASGEVY in treating sickle cell disease. Utilizing cutting edge CRISPR/Cas9 gene editing technology, a patientโs own genes are extracted, edited, and then reinserted to eliminate sickle cell in this new therapy.
December 8, 2023
โ First-ever approval of a CRISPR-based gene-editing therapy in the U.S. โโ Approximately 16,000 patients 12 years of age and older with severe sickle cell disease may now be eligible for this one-time treatment โโ Multiple authorized treatment centers activated โBOSTON & ZUG, Switzerland--(BUSINESS WIRE)--Vertex Ph...
November 30, 2023
Rep. Dan Goldman revived claims that Hunter Biden's laptop was falsified and contains Russian disinformation during a combative House Judiciary hearing.
November 30, 2023
Rep. Dan Goldman revived claims that Hunter Biden's laptop was falsified and contains Russian disinformation during a combative House Judiciary hearing.
November 21, 2023
A major change is great news to residents in the Hudson Valley and Upstate New York.
November 20, 2023
Alberta family with a long history of philanthropic giving funds fellowship in partnership with Calgary Health Foundation...
November 20, 2023
Calgary, Alberta, Canada, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Every 20 seconds, an individual with diabetes loses a limb due to poor foot health. ...
November 19, 2023
In 2021, BoA provided the FBI โ voluntarily and without any legal process โ with a list of individuals who made transactions in the Washington, D.C., metropolitan area using a BoA credit or debit card between Jan. 5-7, 2021.ย
November 18, 2023
A major change is great news to residents in the Hudson Valley and Upstate New York.
November 17, 2023
Rep. Jim Jordan subpoenaed Bank of America after the bank shared private info to the FBI after January 6, 2021.